Advanced search
Start date

Participation of glutamate and nitric oxide on the pathophysiology of neuropsychiatry disorders


Glutamate is well recognized as the main excitatory neurotransmitter in the mammalian central nervous system. Its receptors are classified into ionotropic and metabotropic. Whereas 8 subtypes of the former have already bee recognized, ionotropic glutamate receptors are usually divided into NMDA, AMP A and Kainic subtypes. Glutamate activation of NMDA receptors leads to calcium influx, activation of nitric oxide synthase (NOS) and formation of nitric oxide (NO). In the last decade our group has proposed the participation of glutamate/NO mediated neurotransmission in several neuropsychiatry disorders and brain functions. The main objective of the present project is to continue the investigation of a possible glutamate/NO role on anxiety, affective, motor and psychotic disorders. We also want to test new possible therapeutic approaches to these disorders based on pharmacological interventions on glutamate/NO mediated neurotransmission.Six main groups of projects are proposed. The first four groups are related to pre-clinical studies on animal models (e.g. elevated plus maze, learned helplessness, predator exposure, electrical and/or chemical stimulation of aversive areas, pre-pulse inhibition, catalepsy, motor lesions) and/or Studies of the molecular changes induced by such models or by glutamate/NO related drugs. The last two groups of studies involve clinical research on volunteers and/or patients exposed to models of anxiety (public speaking) or psychosis (ketamine administration) and non-invasive evaluation methods (magnetic resonance imaging, spectroscopy and salivary cortisol evaluation). Considering our previous studies and results from the literature suggesting an interaction between glutamatergic and endocannabinoid systems on psychosis, we will also evaluate a possible antipsychotic effect of cannabidiol, a component of Cannabis sativa. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications (35)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
CRIPPA, JOSE ALEXANDRE S.; DERENUSSON, GUILHERME NOGUEIRA; FERRARI, THIAGO BORDUQUI; WICHERT-ANA, LAURO; DURAN, FABIO L. S.; MARTIN-SANTOS, ROCIO; SIMOES, MARCUS VINICIUS; BHATTACHARYYA, SAGNIK; FUSAR-POLI, PAOLO; ATAKAN, ZERRIN; et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. JOURNAL OF PSYCHOPHARMACOLOGY, v. 25, n. 1, p. 121-130, . (02/13197-2)
ZUARDI, A. W.; CRIPPA, J. A. S.; HALLAK, J. E. C.; PINTO, J. P.; CHAGAS, M. H. N.; RODRIGUES, G. G. R.; DURSUN, S. M.; TUMAS, V.. Cannabidiol for the treatment of psychosis in Parkinson's disease. JOURNAL OF PSYCHOPHARMACOLOGY, v. 23, n. 8, p. 979-983, . (02/13197-2)
BERTOGLIO‚ L.J.; JOCA‚ S.R.L.; GUIMARÃES‚ F.S.. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behavioural Brain Research, v. 175, n. 1, p. 183-188, . (02/13197-2)
BERTOGLIO‚ L.J.; ZANGROSSI‚ H.; OTHERS. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats. Brain Research, v. 1059, n. 1, p. 46-51, . (02/13197-2)
BERTOGLIO‚ L.J.; CAROBREZ‚ A.P.. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology, v. 170, n. 4, p. 335-342, . (02/13197-2)
BERTOGLIO‚ L.J.; DE BORTOLI‚ V.C.; ZANGROSSI JR‚ H.. Cholecystokinin-2 receptors modulate freezing and escape behaviors evoked by the electrical stimulation of the rat dorsolateral periaqueductal gray. Brain Research, v. 1156, p. 133-138, . (02/13197-2)
BEIJAMINI‚ V.; GUIMARÃES‚ F.S.. Activation of neurons containing the enzyme nitric oxide synthase following exposure to an elevated plus maze. Brain Research Bulletin, v. 69, n. 4, p. 347-355, . (02/13197-2)
BEIJAMINI‚ V.; GUIMARÃES‚ F.S.. c-Fos expression increase in NADPH-diaphorase positive neurons after exposure to a live cat. Behavioural Brain Research, v. 170, n. 1, p. 52-61, . (02/13197-2)
PARENTE‚ A.C.B.V.; GARCIA-LEAL‚ C.; DEL-BEN‚ C.M.; GUIMARÃES‚ F.S.; GRAEFF‚ F.G.. Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking. European Neuropsychopharmacology, v. 15, n. 6, p. 663-671, . (02/13197-2)
MOREIRA, FABRICIO DE ARAÚJO; MOLCHANOV, MORIANA LUDMILLA; GUIMARÃES, FRANCISCO SILVEIRA. Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology, v. 171, n. 2, p. 199-203, . (02/13197-2)
RICARDO R. UCHIDA; CRISTINA M. DEL-BEN; DAVID ARAÚJO; GERALDO BUSATTO-FILHO; FÁBIO L.S. DURAN; JOSÉ A.S. CRIPPA; FREDERICO G. GRAEFF. Correlation between voxel based morphometry and manual volumetry in magnetic resonance images of the human brain. Anais da Academia Brasileira de Ciências, v. 80, n. 1, p. 149-156, . (02/13197-2)
SIMONE H. PINHEIRO; HÉLIO ZANGROSSI-JR.; CRISTINA M. DEL-BEN; FREDERICO G. GRAEFF. Elevated mazes as animal models of anxiety: effects of serotonergic agents. Anais da Academia Brasileira de Ciências, v. 79, n. 1, p. 71-85, . (02/13197-2)
SERGIO ISHARA; MARINA BANDEIRA; ANTONIO WALDO ZUARDI. Equipes de serviços psiquiátricos públicos: avaliação da satisfação. Revista Brasileira de Psiquiatria, v. 30, n. 1, p. 38-41, . (02/13197-2)
R.F. SANCHES; J.A.S. CRIPPA; J.E.C. HALLAK; J.P.M. DE SOUSA; D. ARAÚJO; A.C. SANTOS; A.W. ZUARDI. Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia. Brazilian Journal of Medical and Biological Research, v. 41, n. 12, p. 1132-1141, . (02/13197-2)
J.A.S. CRIPPA; R. UCHIDA; G.F. BUSATTO; F.S. GUIMARÃES; C.M. DEL-BEN; A.W. ZUARDI; A.C. SANTOS; D. ARAÚJO; P.K. MCGUIRE; F.G. GRAEFF. The size and prevalence of the cavum septum pellucidum are normal in subjects with panic disorder. Brazilian Journal of Medical and Biological Research, v. 37, n. 3, p. 371-374, . (98/10639-7, 99/12205-7, 02/13197-2)
ROSANA SHUHAMA; CRISTINA M. DEL-BEN; SÔNIA R. LOUREIRO; FREDERICO G. GRAEFF. Animal defense strategies and anxiety disorders. Anais da Academia Brasileira de Ciências, v. 79, n. 1, p. 97-109, . (02/13197-2)
JOSÉ ALEXANDRE CRIPPA; ACIOLY L T LACERDA; EDSON AMARO; GERALDO BUSATTO FILHO; ANTONIO WALDO ZUARDI; RODRIGO A BRESSAN. Efeitos cerebrais da maconha: resultados dos estudos de neuroimagem. Revista Brasileira de Psiquiatria, v. 27, n. 1, p. 70-78, . (02/13197-2)
DE OLIVEIRA, DANIELLE C. G.; ZUARDI, ANTONIO W.; GRAEFF, FREDERICO G.; QUEIROZ, REGINA H. C.; CRIPPA, JOSE A. S.. Anxiolytic-like effect of oxytocin in the simulated public speaking test. JOURNAL OF PSYCHOPHARMACOLOGY, v. 26, n. 4, p. 497-504, . (02/13197-2)
VALVASSORI, SAMIRA S.; ELIAS, GUILHERME; DE SOUZA, BRUNA; PETRONILHO, FABRICIA; DAL-PIZZOL, FELIPE; KAPCZINSKI, FLAVIO; TRZESNIAK, CLARISSA; TUMAS, VITOR; DURSUN, SERDAR; NISIHARA CHAGAS, MARCOS HORTES; et al. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. JOURNAL OF PSYCHOPHARMACOLOGY, v. 25, n. 2, p. 274-279, . (02/13197-2)
ZUARDI, A. W.; CRIPPA, J. A. S.; DURSUN, S. M.; MORAIS, S. L.; VILELA, J. A. A.; SANCHES, R. F.; HALLAK, J. E. C.. Cannabidiol was ineffective for manic episode of bipolar affective disorder. JOURNAL OF PSYCHOPHARMACOLOGY, v. 24, n. 1, p. 135-137, . (02/13197-2)
CRIPPA‚ J.A.S.; ZUARDI‚ A.W.; BUSATTO‚ G.F.; SANCHES‚ R.F.; SANTOS‚ A.C.; ARAÚJO‚ D.; AMARO‚ E.; HALLAK‚ J.E.C.; NG‚ V.; MCGUIRE‚ P.K.. Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. EUROPEAN PSYCHIATRY, v. 21, n. 5, p. 291-299, . (98/10639-7, 99/12205-7, 02/13197-2)
BERTOGLIO‚ L.J.; ANZINI‚ C.; LINO-DE-OLIVEIRA‚ C.; CAROBREZ‚ A.P.. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats. Behavioural Brain Research, v. 162, n. 1, p. 99-107, . (02/13197-2)
DE LIMA OSÓRIO‚ F.; CRIPPA‚ J.A.; LOUREIRO‚ S.R.. A study of the discriminative validity of a screening tool (MINI-SPIN) for social anxiety disorder applied to Brazilian university students. EUROPEAN PSYCHIATRY, v. 22, n. 4, p. 239-243, . (02/13197-2)
GARCIA-LEAL‚ C.; PARENTE‚ A.C.B.V.; DEL-BEN‚ C.M.; GUIMARÃES‚ F.S.; MOREIRA‚ A.C.; ELIAS‚ L.L.K.; GRAEFF‚ F.G.. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. PSYCHIATRY RESEARCH, v. 133, n. 2-3, p. 239-252, . (02/13197-2)
DOS SANTOS‚ L.; DE ANDRADE‚ T.G.C.S.; ZANGROSSI JUNIOR‚ H.. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. European Neuropsychopharmacology, v. 18, n. 4, p. 286-294, . (02/13197-2)
CRIPPA, JOSE ALEXANDRE S.; OSORIO, FLAVIA DE LIMA; DEL-BEN, CRISTINA MARTA; SANTOS FILHO, ALAOR; DA SILVA FREITAS, MARIA CECILIA; LOUREIRO, SONIA REGINA. Comparability between telephone and face-to-face Structured Clinical Interview for DSM-IV in assessing social anxiety disorder. PERSPECTIVES IN PSYCHIATRIC CARE, v. 44, n. 4, p. 241-247, . (02/13197-2)
GUIMARÃES, F. S.; MOREIRA, F. A.; AGUIAR, D. C.; DE LUCCA, A. C. B.; BEIJAMINI, V.. Role of nitric oxide in brain regions related to defensive reactions. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, v. 29, n. 8, p. 1313-1322, . (02/13197-2)
CAROBREZ, A. P.; BERTOGLIO, L. J.. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, v. 29, n. 8, p. 1193-1205, . (02/13197-2)
MOREIRA, FABRÍCIO DE ARAÚJO; GUIMARÃES, FRANCISCO SILVEIRA. Role of serotonin receptors in panic-like behavior induced by nitric oxide in the rat dorsolateral periaqueductal gray: effects of chronic clomipramine treatment. Life Sciences, v. 77, n. 16, p. 1972-1982, . (02/13197-2)

Please report errors in scientific publications list using this form.